Nine more manufacturers join the MFN program, pairing new Medicaid pricing deals with $19.6B in U.S. manufacturing investment ...
Most-Favored-Nation rhetoric and international reference proposals can become practical anchors despite unclear ...
Cencora's Gregg Gorniak breaks down what separates basic DSCSA compliance from using it to streamline transactions and strengthen trading partnerships. Meeting DSCSA's letter and building genuine ...
Cardinal Health's Liberty Dewey breaks down the NDC-12 transition timeline and the vendor, association and wholesaler support ...
HDA's Kala Shankle says a two-year national licensure runway for distributors could work, but only if states, the FDA and industry move in parallel. A proposed two-year implementation window may sound ...
HDA's Kala Shankle explains what a national licensure standard could mean for wholesale distributors and 3PLs, and why its ...
The biosimilar market is smaller but rapidly expanding. As more blockbuster biologics lose exclusivity across immunology, ...
Ahead of HDA's 2026 Traceability Seminar, Cencora's Gregg Gorniak explains how AI and RFID are being used to catch DSCSA data ...
McKesson's Scott Mooney discusses the technical and operational challenges of DSCSA compliance, from linking ERP systems to EPCIS to recurring friction in 340B transaction data exchange. Serialized ...
Of the seven principles set out in the Council for International Organizations of Medical Sciences Working Group (CIOMS) ...
Cencora's Ameer Ali explains how the shift to NDC-12 is reshaping supply chain systems and why readiness still varies widely across manufacturers. As the FDA's shift to 12-digit National Drug Codes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results